RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,728,000 | -16.3% | 1,600,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,064,000 | -2.3% | 1,600,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $2,112,000 | -12.0% | 1,600,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,400,000 | +26.8% | 1,600,000 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $1,892,000 | +4.4% | 1,600,000 | -0.2% | 0.00% | 0.0% |
| Q2 2022 | $1,812,000 | -62.2% | 1,603,252 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $4,794,000 | +12.8% | 1,603,252 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,249,000 | -27.0% | 1,603,252 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $5,820,000 | -16.4% | 1,603,252 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $6,958,000 | +26.9% | 1,603,252 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $5,483,000 | -2.4% | 1,603,252 | -0.1% | 0.01% | 0.0% |
| Q4 2020 | $5,617,000 | +45.8% | 1,604,794 | 0.0% | 0.01% | +14.3% |
| Q3 2020 | $3,852,000 | +31.2% | 1,604,794 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $2,937,000 | +17.7% | 1,604,794 | +0.3% | 0.01% | 0.0% |
| Q1 2020 | $2,496,000 | -27.1% | 1,600,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $3,424,000 | +14.4% | 1,600,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $2,992,000 | -76.1% | 1,600,000 | -66.7% | 0.01% | -28.6% |
| Q2 2019 | $12,528,000 | +204.7% | 4,800,000 | +200.0% | 0.01% | 0.0% |
| Q1 2019 | $4,112,000 | +11.7% | 1,600,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $3,680,000 | -28.3% | 1,600,000 | 0.0% | 0.01% | -12.5% |
| Q3 2018 | $5,136,000 | +13.4% | 1,600,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $4,528,000 | +42.1% | 1,600,000 | +77.8% | 0.01% | +33.3% |
| Q1 2018 | $3,186,000 | +4.7% | 900,000 | +14.8% | 0.01% | +20.0% |
| Q4 2017 | $3,042,000 | +63.1% | 784,088 | +6.8% | 0.01% | +66.7% |
| Q3 2017 | $1,865,000 | +7.6% | 734,088 | +15.6% | 0.00% | 0.0% |
| Q2 2017 | $1,734,000 | -1.6% | 635,000 | +19.3% | 0.00% | 0.0% |
| Q1 2017 | $1,762,000 | – | 532,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |